Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for CLARITHROMYCIN
- Vonoprazan for Helicobacter Pylori Eradication in Adolescents
- Fourteen-Day Vonoprazan-Based Dual Therapy With Amoxicillin as First-Line Helicobacter Pylori Treatment in Comparison With Extended Sequential Therapy
- Bismuth Quadruple Therapy Versus Standard Triple Therapy
- Potassium Copetitive Acid Blockers Efficacy in H.Pylori Eradication
- Efficacy of Amoxicillin-Esomeprazole HDDT Compared to Levofloxacin Triple Therapy for H. Pylori Eradication: A RCT
- Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine
- A Comparative Study Between Concomitant Versus Load Therapy in Eradication of Helicobacter Pylori Infection
- A Study to Investigate Effect of Clarithromycin, a Strong CYP3A4 Inhibitor, on Brensocatib Pharmacokinetics in Healthy Participants
- A "Screen and Treat" Helicobacter Pylori Eradication Trial in Adolescents in Three Regions of Chile
- Role of Vitamin D Supplementation as an Adjuvant Therapy inTreatment of Helicobacter Pylori in Children
- Recurrence Rate Comparison Between Esomeprazole and Lansoprazole in Eradicating Helicobacter Pylori Infection Among Children
- Efficacy and Safety of Rifasutenizol (TNP 2198) in Participants With H. Pylori Infection
- The Potential of Givinostat as DDI Victim in Co-administration P-gp Inhibitor (Part 2)
- Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology
- Efficacy of Therapy Based on Fecal Molecular Antimicrobial Susceptibility Tests for Helicobacter Pylori Infection
- Electrophysiological Effects of Potential QT Prolonging Drugs
- IMPROVEMENT in ERADICATION of H-PYLORI INFECTION
- Effect of Probiotics on Eradication of Persistent H.Pylori Infection
- Optimized Bismuth Quadruple Therapy vs Triple Standard Therapy for Helicobacter Pylori Eradication
- Optimized-dose Amoxicillin Versus Standard-dose Amoxicillin for Quadruple Therapy in Helicobacter Pylori Eradication
- Effect of Clarithromycin on PK of Linaprazan, Linaprazan on PK of Clarithromycin and Linaprazan on PK of Midazolam
- Vonoprazan-based Therapy Versus Standard Regimen for Helicobacter Pylori Infection Management
- Clarithromycin Susceptibility-Guided Treatment of Helicobacter Pylori Infection
- Perpetrator DDI Potential of Givinostat as Inhibitor and Inducer of CYP3A and P-gp Activity
- A Drug Interaction Study of Clarithromycin and LY3502970 in Healthy Participants
- Influence of Oral Hp Infection and Oral Related Factors on Gastric Hp Infection and Eradication Therapy
- Antibiotyping and Prevalence of Virulent Genotypes Among Helicobacter Pylori and Their Impact on Response to Therapy
- Bioequivalence Study of Klaribact (Clarithromycin) 500 mg, Film Coated Tablet.
- Efficacy and Safety of Dual Therapy as First-line Treatment for Hp Infection
- Drug-Drug Interaction Study of Voriconazole With Clarithromycin.
- High Dose Dual Therapy vs Clarithromycin Triple Therapy for Treatment Naive H Pylori Infection in an Urban Population
- Bioequivalence Study of Klaribact 125mg/5ml, Suspension
- Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection
- Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment
- Helicobacter Pylori Eradication With Probiotics Combined With Triple Therapy Versus Bismuth-containing Quadruple Therapy
- Influencing Factors of Helicobacter Pylori Infection and Eradication Failure
- Drug-drug Interactions and Safety Among JP-1366, Amoxicillin, and Clarithromycin in Healthy Volunteers
- The Evaluation of Triple Therapy With Vonoprazan, Amoxicillin and Bismuth for Eradication of Helicobacter Pylori
- Nitazoxanide and Lansoprazole Based Regimens for H. Pylori Management
- Beta-Lactam Containing Regimen for the Shortening of Buruli Ulcer Disease Therapy
- Efficacies of Hybrid and High-dose Dual Therapies for the First-line Anti-H Pylori Treatment - a Randomized Trial
- A Phase 1 Drug-Drug Interaction Study Between ATI-2173 and Midazolam or Clarithromycin in Healthy Subjects
- Effects of Edoxaban on Platelet Aggregation
- Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection
- Helicobacter Pylori Eradication and Follow-up
- Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication
- Efficacy of Clarithromycin and Flouroquinolones Based Regimens in H.Pylori Eradication in Covid-19 Era
- Antibiotic Combination for H. Pylori Eradication in Penicillin-allergic Patients
- Study on The Efficacy and Safety of Berberine-containing Triple Therapy in Helicobacter Pylori First-Line Eradication
- Effect of Clarithromycin and Rifampicin on the Pharmacokinetics of XZP-3287 in Healthy Subjects
- Vonoprazan in Helicobacter Pylori Treatment an RCT
- Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days
- ILTHPI - Comparison of Medicament Containing Tetracycline, Metronidazole, Bismuth Versus Amoxicillin, Metronidazole, Clarithromycin
- Treatment of Selinexor in Combination With Clarithromycin, Pomalidomide and Dexamethasone for Relapsed Refractory Multiple Myeloma Patients
- 14-day Quadruple Therapy Versus Triple Therapy in HP Eradication
- A Study of Vonoprazan in Adults With Helicobacter Pylori
- Anti-inflammatory Action of Oral Clarithromycin in Community-acquired Pneumonia
- Comparison of Efficacy of Triple Regimen Based on Clarithromycin VS Metronidazole in Children
- Comparison of Vonoprazan-based Versus Lansoprazole-based Triple Therapy, High Dose Dual Therapy, Bismuth and Non-bismuth Quadruple Therapy in the First-line Treatment of Helicobacter Pylori Infection
- Helicobacter Pylori Eradication in Functional Dyspepsia
- Helicobacter Pylori Eradication With Berberine Plus Amoxicillin Triple Therapy Versus Bismuth-containing Quadruple Therapy
- Effect of Long Term Clarithromycin for Prevention of Exacerbations in Non-cystic Fibrosis Bronchiectasis in Asian Populations
- Comparison of Two Corticosteroid Regimens for Post COVID-19 Diffuse Lung Disease
- Effectiveness of Rifabutin for Treatment of Helicobacter Pylori
- A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
- Clarithromycin Versus Azithromycin in Treatment of Mild COVID-19 Infection
- Quadruple vs Tailored Therapy in the Treatment of Helicobacter Pylori Infection
- Comparing Different Regimens for Eradication of Helicobacter Pylori in Kuwait
- Comparing the Efficacy of 10-day Reverse Hybrid Therapy and 10-day Triple Therapy Plus Bismuth Therapy.
- Effectiveness of Minocycline-Containing Bismuth Quadruple Therapy for Helicobacter Pylori Eradication
- Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies
- The Efficacy of 10-day and 14-day Bismuth-based Quadruple Therapy in First-line H. Pylori Eradication
- Assessment and Management of Chronic Dyspepsia in Eastern Uganda
- Lactoferrin in Helicobacter Pylori Eradication Either With Standard Triple Therapy or Sequential Therapy
- Pharmacokinetic Interactions of Quadruple Therapy With Anaprazole/Amoxicilin/Clarithromycin/Bismuth
- Study of Nitazoxanide (NTZ) for Helicobacter Pylori in Children
- Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early
- Isotretinoin in Treatment of COVID-19
- Prospective Randomised Trial of First and Second Line Treatments of RCT of First and Second Line H Pylori Treatments in Slovenia
- Susceptibility Testing Guided Versus Empirical Therapy for Refractory H. Pylori Infection
- Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection
- Finding the Optimal Regimen for Mycobacterium Abscessus Treatment
- A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab
- Study of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) Patients
- Helicobacter Pylori Eradication With Different Bismuth Quadruple Therapies
- A Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral Vonoprazan (TAK-438) 20 mg Compared to Esomeprazole 20 mg Twice Daily in Paticipants With Helicobacter Pylori Infection
- The Role of Probiotics in the Eradication of Helicobacter Pylori
- Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Helicobacter Pylori Infection
- Helicobacter Pylori Eradication According to DPO-PCR Methods
- The Epidemiology and Optimal Treatment of Helicobacter Pylori in Myanmar
- Triple Therapy With Tegoprazan in H. Pylori Positive Patients_PILOT
- Helicobacter Pylori First-line Treatment in Patients Allergic to Penicillin
- Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection.
- A Comparison of High-dose Dual Therapy and Half-dose Clarithromycin-containing Bismuth Quadruple Therapy for H.P Eradication in Elderly Patients
- A Drug Interaction Study of KW-6356 and Clarithromycin or Rifampicin
- EFFICACY OF ORAL AROEIRA (Schinus Terebinthifolius Raddi), AMOXYCILLIN AND CLARITROMYCIN FOR Helicobacter Pylori ERADICATION IN GASTRITE AND SYMPTOM PATIENTS
- Clinical Trial of Clarithromycin, Lenalidomide and Dexamethasone in the Treatment of the First Relapsed Multiple Myeloma
- Tailored Juice-guided Eradication Therapy
- A Study Using Whole-body PET After Oral Microdose of 18F-labeled Liporaxel in Patients With Solid Tumor
- Comparison Between Quadruple Regimens for Helicobacter Pylori Infection in Egypt
- Clarithromycin Mechanisms in Hypersomnia Syndromes
- Acceptance of Clarithromycin in a Straw Compared to Syrup in Children With Upper Respiratory Tract Infections
- Assesment of the Efficiency and Safety Helicobacter Pylori Therapy With or Without Saccharomyces Boulardii
- ADDITION OF BISMUTH TO THE STANDARD TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION
- A RCT of Triple Therapy With Proton Pump Inhibitor vs Vonoprazan for Helicobacter Pylori Gastritis
- Intraluminal Mono-antibiotic Therapy for Helicobacter Pylori Infection - A Comparison of Levofloxacin Powder and Levofloxacin Solution
- The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB
- Dexlansoprazole MR-Based Concomitant Quadruple Therapy
- Immunomodulatory Effect of Macrolides in Naturally Occurring Influenza Virus Infections in the Community
- Daily Four Times or Two Times Usage of PPI and Amoxicillin for the First or Second Line H. Pylori Eradication
- A Study to Assess the Drug-Drug Interaction Between Bedaquiline and Clarithromycin in Healthy Adult Participants
- Comparing the Efficacy of Hybrid, High-dose Dual and Bismuth Quadruple Therapies
- THE EFFECT OF HELICOBACTER PYLORI ERADICATION THERAPY TO GASTRIC WALL THICKNESS BEFORE THE LAPAROSCOPIC SLEEVE GASTRECTOMY
- Probiotics in the Reduction of Adverse Effects and Dysbiosis of H. Pylori Eradication
- A Comparison of Clarithromycin-based and Furazolidone-based Bismuth-containing Regimens for H. Pylori Eradication
- Pharmacokinetics Study to Evaluate Drug-Drug Interactions and Safety of Elpida® in Co-Administration With Other Drugs
- Tailored Therapy for Helicobacter Pylori Treatment in Patients With Penicillin Allergy
- Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population
- Evaluation of Saccharomyces Boulardii Combined With Standard Quadruple Therapy for Eradication of Helicobacter Pylori
- Helicobacter Pylori Eradication Rates of Bismuth-containing Quadruple Therapy vs Modified Quadruple Therapy in Korea
- Anti-chlamydophila Antibiotic Combination Therapy in the Treatment of Patients With Coronary Heart Disease
- Concomitant Versus Hybrid Regimen for H. Pylori Eradication
- Genotypic Resistance Guided Versus Susceptibility Testing Guided Therapy for the First-line Eradication of H. Pylori
- Intraluminal Metronidazole Powder Monotherapy for Helicobacter Pylori Infection
- Intraluminal Amoxicillin Powder Monotherapy for Helicobacter Pylori Infection
- Intraluminal Clarithromycin Powder Monotherapy for Helicobacter Pylori Infection
- Triple Therapy With Tegoprazan in H. Pylori Positive Patients
- A Unique Regimen for Treatment of Helicobacter Pylori Infection
- Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of After Administrations of DWP14012 Alone and Combinations of DWP14012, Clarithromycin and Amoxicillin in Healthy Male Subjects
- Modulation of GABA-A Receptors in Parkinson Disease-Transdermal Flumazenil Arm
- Tailored Therapy for Clarithromycin-Resistant H. Pylori
- Safety Trial of Herbal Melanin in Gastritis Patients
- Macrolides for KCNJ5 - Mutated Aldosterone-Producing Adenoma (MAPA)
- Tailored Therapy for Helicobacter Pylori Rescue Treatment
- Comparison of Two Novel First-line Anti-Helicobacter Pylori Therapy
- Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients
- Eradication of H-pylori in Pregnancy and Its Effect on Iron Replacement Therapy?
- Benefit of Clarithromycin in Patients With Severe Infections Through Modulation of the Immune System
- Comparing the Efficacy of 14-day Reverse Hybrid Therapy and 14-day Triple Therapy Plus Bismuth Therapy
- A Phase 3 Study to Evaluate the Efficacy and Safety of Triple Therapy With CJ-12420 in H. Pylori Positive Patients
- Bismuth Based Quadruple Therapy 10 Days in Children
- Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor
- Flufenamic Acid for Hospitalised Influenza Infection
- CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections
- The Effect of Broccoli Sprout Extract and Probiotics for Eradication of Helicobacter Pylori
- Sequential Versus Quadruple Therapy in the Second-line Treatment
- ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active Comparator
- S. Aureus Decolonization in HPN Patients.
- The Effects of a Synbiotic Addition on Eradication Therapy of Helicobacter Pylori Infection in Children
- Sequential Therapy Versus Quadruple Therapy in H. Pylori Eradication
- Nonsurgical Periodontal Treatment Associated or Not With Systemic Antibiotics and Photodynamic Therapy
- Effect of Vitamin D on Drug Resistant Helicobacter Pylori (HP) Eradication Study
- Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori Treatment
- 10 vs 14 Days Triple Therapy : H.Pylori Infection Eradication
- Periodontal Debridement Associated With Systemic Antibiotics and Single/Repeated PDT to Treat Aggressive Periodontitis
- Intraluminal Therapy for Helicobacter Pylori Infection
- Rifaximin Associated With Classic Triple Therapy for the Eradication of Helicobacter Pylori Infection
- Cohorts of Docetaxel or Cabazitaxel in Combination With the Potent CYP3A4 Inhibitor, Clarithromycin
- Clarithromycin + Lenalidomide Combination: a Full Oral Treatment for Patients With Relapsed/Refractory Extranodal Marginal Zone Lymphoma
- Comparison Efficacy of 14-day Concomitant Therapy:Clarithromycin vs.Levofloxacin in Eradication of H.Pylori
- To Investigate PK and PD of CJ-12420, Clarithromycin, Amoxicillin After Multiple Dose Administration
- Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Clarithromycin, Amoxicillin and Ilaprazole
- Clarithromycin,Lenalidomide and Dexamethasone for Relapsed/Refractory Myeloma
- Two Different Antibiotic Agents to Treat Generalized Aggressive Periodontitis
- 10-day Versus 14-day Concomitant PAMC as First-line Treatment Strategy for the Eradication of H. Pylori Infection
- Tailored Versus Empiric Therapy for Helicobacter Pylori Treatment
- Efficacy and Saafety of Omez Iin Patients With H.Pylori Associated Diseases
- Effect of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Participants
- TAK-438 Bismuth Drug Interaction Study
- Efficacy and Safety of 1-week Triple Therapy With Ilaprazole for the Eradication of Helicobacter Pylori
- A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLC
- Efficacy and Safety of Ilaprazole Based Bismuth-containing Quadruple Regimen for the First-line Treatment of Helicobacter Pylori Infection
- Clarithromycin as Adjuvant to Periodontal Debridement
- Comparison of Vonoprazan-based Dual and Triple Therapies for H. Pylori Eradication
- To Evaluate the Effect of Clarithromycin on the Systemic Exposure of Pacritinib in Healthy Subjects
- Modified Non-clarithromycin Triple Therapy in Eradicating Helicobacter Pylori
- TAK-438_110 Drug Interaction With Cytochrome P450 3A4 (CYP3A4) Inhibitor Clarithromycin
- Randomized Controlled Trial Comparing Long and Short Duration of Antibiotic Prophylaxis for Patients Undergoing Sinus Lift Surgery
- Eradication of H. Pylori Therapy Individualized by the Mutation of 23S rRNA of H. Pylori
- Development of Treatment Algorithm for Eradication of Helicobacter Pylori Based on Antibiotic Susceptibility Test
- Clarithromycin Triple Therapy Plus Bismuth for Helicobacter Pylori First-line Treatment
- Triple Therapy Versus Levofloxacin-based Therapy for Helicobacter Pylori Eradication in Mexico.
- Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection
- Comparison Efficacy of 14-day Triple Therapy: Clarithromycin vs. Levofloxacin on Eradication of H. Pylori
- The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori Patients
- Tailored Therapy for Helicobacter Pylori in Children
- Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Clarithromycin Quadruple Therapy
- Clarithromycin, Sulfamethoxazole/Trimethoprim or Observation in Newly Diagnosed Multiple Myeloma
- GEM-CLARIDEX: Ld vs BiRd
- Clarithromycin in Multiple Myeloma Induction Therapy
- Comparison of 7-day PPI-based Standard Triple Therapy and 10-day Bismuth Quadruple Therapy for H. Pylori Eradication
- High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori Infection
- Ixazomib With Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients With Multiple Myeloma
- Comparison of Hybrid and Bismuth Quadruple Therapies for Helicobacter Pylori Eradication
- BiRd vs. Rd as Initial Therapy in Multiple Myeloma
- Study of Levofloxacin-based Concomitant Therapy for H. Pylori Eradication in Diabetic Patients
- Study in Healthy Male Subjects to Evaluate the Effect of Itraconazole and Rifampicin on the PK of Fedovapagon
- Study of Nitazoxanide (NTZ) Based New Therapeutic Regimens for Helicobacter Pylori
- Is Clarithromycin a Potential Treatment for Cachexia in People With Lung Cancer?
- Efficacy on Helicobacter Pylori Eradication With Two Antibiotic Regimens
- Dabigatran in an Interaction Probe Drug Cocktail
- The Diagnostic Validity of the Urea Breath Test
- Clarithromycin is an Adjunct to Scaling and Root Planing
- Comparison of 12-day Reverse Hybrid Therapy and 12-day Standard Triple Therapy for Helicobacter Pylori Infection
- The Role of Chronotropic Incompetence in Heart Failure With Normal Ejection Fraction (HFNEF)
- A Study to Evaluate the Absolute Bioavailability of Intranasal and Oral Esketamine and the Effects of Clarithromycin on the Pharmacokinetics of Intranasal Esketamine in Healthy Participants
- Selinexor and Backbone Treatments of Multiple Myeloma Patients
- Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Bismuth-containing Quadruple Therapy
- Evaluate Effects of Multiple Doses of Rifampin and Clarithromycin on the Single Dose Pharmacokinetics of Deflazacort
- Drug-Drug Interaction Study in Healthy Adult Volunteers
- Effects of Single-dose and Steady-state TPV/r on the Steady-state Pharmacokinetics of Clarithromycin and a Preliminary Assessment of the Effects of a Standard High-fat Test Meal on the Steady-state Pharmacokinetics of Tipranavir
- Efficacy of Acetylcysteine-containing Triple Therapy in the First Line of Helicobacter Pylori Infection
- Clarithromycin Plus CTd Regimen for Patients With Newly Diagnosed Multiple Myeloma
- A Study to Assess Effects of Clarithromycin on Pharmacokinetics of JNJ-54861911 in Healthy Male Participants
- Pomalidomide for Lenalidomide for Relapsed or Refractory Multiple Myeloma Patients
- Efficacy of Macrolide and Glucocorticoid in the Treatment of Chronic Rhinosinusitis After Endoscopic Sinus Surgery
- High Dose Amoxicillin Versus Tetracycline as Second-line Treatment of Resistant Helicobacter Pylori Infection
- Amoxicillin/Metronidazole Based Quadruple Therapy for Helicobacter Pylori Eradication
- Bioavailability of Dabigatran With or Without Clarithromycin in Healthy Volunteers
- Compare Sequential and Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea
- Optimization of MDR-TB Treatment Regimen Based on the Molecular Drug Susceptibility Results of Pyrazinamide
- A Study of LY2835219 in Participants With Cancer
- Effects of Helicobacter Pylori Infection Eradication in Patients With Parkinson's Disease
- Comparison of the Eradications Rates of Sequential Therapy Versus Concomitant Therapy
- RCT: Triple vs Sequential vs Concomitant Therapy H Pylori
- A Randomized, Open-label Study on Helicobacter Pylori Eradication With Standard Triple Regimen Plus Acetazolamide
- Study to Evaluate the Interaction Potential of Clarithromycin XL on Diltiazem Hydrochloride Cream 2% in Healthy Subjects
- Risk of QT-prolongation and Torsade de Pointes in Patients Treated With Acute Medication in a University Hospital
- Drug-Drug Interaction Study Between CJ-12420 and Clarithromycin in Healthy Male Subjects
- An Open-Label Trial Of Reduced- Dose Pylera, Amoxicillin, and Esomeprazole in the Treatment Of Helicobacter Pylori Infection
- CYP3A4 Induction and Mineral Homeostasis
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
- Prospective Study : Helicobacter Pylori Eradication Therapy in Accordance With Past Antibiotics Use
- Concomitant Therapy of H. Pylori
- Eradication Rates of Helicobacter Pylori and Its Affecting Factors
- The PK and PD Interaction Between YH4808, Amoxicillin and Clarithromycin in Healthy Subjects
- Triple Therapy Versus Quadruple Therapies in the First Line Therapy of Helicobacter Pylori Infection
- High Dose PPI Triple Therapy Versus Sequential Therapy for Helicobacter Pylori Eradication
- 15-day Sequential Therapy for Helicobacter Pylori Infection in Korea
- The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-alcoholic Fatty Liver Disease
- Pharmacokinetic Study of Clarithromycin in Very Low Birth Weight (VLBW)
- The Effect of Gemfibrozil, Ketoconazole and Clarithromycin on the Amount of LY2409021 in the Bloodstream
- Concomitant, Sequential, and Standard Triple Therapy for H. Pylori Infection
- Quadruple Versus Sequential Therapy for Helicobacter Pylori Eradication
- Helicobacter Pylori Eradication in Subjects With Non-alcoholic Fatty Liver Disease
- Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma
- Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection
- Improving Tolerance of Treatment of Pulmonary MAC Infections
- Helicobacter Pylori Eradication in Diabetic Subjects With Non-alcoholic Fatty Liver Disease
- Bismuth Improves the Efficacy of Levofloxacin-containing Triple Therapy for Helicobacter Pylori Treatment
- Aizthromycin or Clarithromycin in H-pylori Eradication Regimen
- Efficiency Study of Clarithromycin and Bismuth-containing Quadruple Therapy to Treat H.Pylori
- WHO Drug Study for Buruli Ulcer - Comparison of SR8 and CR8
- Helicobacter Pylori Eradication in Non-diabetic Non-alcoholic Steatohepatitis
- Clarithromycin Prophylaxis in Preterm Infants Colonisation With Ureaplasma Urealyticum and Mycoplasma Hominis
- Clarithromycin-based Triple Therapy for 14 Days Versus Sequential Therapy 10 Days in the First Line Therapy
- Lactobacillus Reuteri in Management of Helicobacter Pylori Infection in Dyspeptic Patients
- Efficacy of Seven-day Combined Rabeprazole Plus Levofloxacin Plus Augmentin for Eradication of Helicobacter Pylori
- Comparison Between Ten Days Sequential Treatment and Traditional Three Combined Treatment of Helicobacter Pylori
- Increased Re-eradication Rate of Helicobacter Pylori by Adding N-acetylcystein or Metronidazole to the Triple Therapy
- Rabeprazole Based Sequential-Concommitant Hybrid Therapies for H. Pylori Infections
- Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple Myeloma
- Drug Interaction Study Between Linezolid and Clarithromycin in Tuberculosis Patients
- Salvage Therapy With High Dose Oral Clarithromycin in Relapsed or Refractory Extranodal Marginal Zone Lymphoma
- Efficacy of TAK-438, Amoxicillin and Clarithromycin in the First Line Eradication of H. Pylori
- Duration of Antibiotics Treatment With Cefazolin and Clarithromycin in Women With Preterm Premature Rupture of Membrane
- Sequential Therapy Versus Quadruple Therapy as Second Line Treatment After Failure of the Standard Triple Therapy for H Pylori Infection
- 14-day Quadruple Hybrid vs. Concomitant Therapies for Helicobacter Pylori Eradication
- A Study to Evaluate the Effect of Clarithromycin on LY2216684
- Pharmacokinetics Study of Oral IXAZOMIB in Participants With Advanced Nonhematologic Malignancies or Lymphoma
- Risk of Acute Liver Injury in Users of Antimicrobials
- Influence of OATP1B1 and CYP2C9 Genotypes on the Pharmacokinetics of Bosentan Before and During Clarithromycin
- Effects of Clopidogrel and Clarithromycin on the Oral Disposition of Sibutramine in Healthy Subjects
- Antibiotics Study in Preterm Premature Rupture of the Membranes
- Investigation Drug-drug Interaction Between Dabigatran and Clarithromycin
- Administration of Tadalafil in Conjunction With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma
- Outcome Study to Evaluate Klaricid XL® (Clarithromycin Modified Release) in Patients With Acute Exacerbation of Chronic Bronchitis
- Generic Formulations of Commonly-used Oral Drugs in Saudi Arabia:Interchangeability & Post-marketing Quality
- H. Pylori Eradication Using Pyklear in Adults in El Paso, Texas: a Pilot Study
- Efficacy of Clarithromycin Treatment in Prevention of Chronic Lung Disease in Premature Infants
- Five Days Quadruple and Clarithromycin Containing Triple Therapy as Treatment for Helicobacter Pylori Eradication
- Treatment of Mycobacterium Xenopi Pulmonary Infection
- Influence of Pharmacogenetic Factors, Paroxetine and Clarithromycin on Pharmacokinetics of Clomiphene
- Study Comparing Sequential and Concomitant Therapy for Helicobacter Pylori Eradication in Routine Clinical Practice
- Efficacy of 10-day Concomitant Regimen Versus High Dose Dual Therapy in Anti-Helicobacter Pylori Rescue Therapy
- Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines
- Clarithromycin as Immunomodulator for the Management of Sepsis
- A Trial of Standard vs Half Dose Rabeprazole, Clarithromycin, Metronidazole and Amoxicillin in the Treatment of Helicobacter Pylori Infection
- Molecular Detection of Antibiotic Resistance and H Pylori Eradication
- Mixed Strain H. Pylori Infection in Patients Who Have Problems With Eradication of H. Pylori
- Efficacy of High Dose Dual Therapy, Sequential Therapy and Triple Therapy in H. Pylori Eradication
- Study of Decadron, Biaxin, and Pomalidomide in Relapsed/Refractory Myeloma
- Clarithromycin for the Treatment of Hypersomnia
- Efficacy and Safety Evaluation of Levofloxacin Triple Therapy for Helicobacter Pylori Eradication
- Evaluation of the Treatment With Klacid SR in Patients With Acute Tracheitis, Tracheobronchitis and Bronchitis, Acute Exacerbation of Chronic Bronchitis and Mild Community-acquired Pneumonia in Common Clinical Practice in Ukraine
- Sequential and Hybrid Therapies for H Pylori Infection
- Recovery Time in Children With Lower Respiratory Tract Infections Treated With Klacid® Granules for Oral Suspension.
- Recovery Time in Thai Patients With Upper or Lower Respiratory Tract Infections Treated With Klacid MR
- Clarithromycin Modified Release Observational Study for Evaluation of Treatment, Tolerability & Recovery Time in Saudi & Egyptian Clinical Settings (CLOSER)
- S0701, Trial of Three Antibiotic Regimens to Eradicate Helicobacter Pylori (H. Pylori)
- Efficacy of 10-day and 14-day Sequential Therapy Versus Triple Therapy on the Eradication of Helicobacter Pylori
- The Efficacy of Susceptibility Test -Driven Sequential Therapy as the Third Line Therapy for Refractory Helicobacter Pylori Infection
- Clinical Study to Evaluate the Efficacy and the Safety of Eradication Therapy for Helicobacter Pylori in Functional Dyspepsia
- Efficacy of Acetilcysteine in 'Rescue' Therapy for Helicobacter Pylori Infection. Pilot Study
- Drug-Drug Interaction Study of Colchicine and Clarithromycin
- The Efficacy of Sequential Therapy as Second Line Therapy for Refractory Helicobacter Pylori Infection - A Pilot Study
- To Demonstrate the Relative Bioavailability of Clarithromycin 250 mg Tablets Under Fasting Conditions
- To Demonstrate the Relative Bioavailability of Clarithromycin 250 mg Tablets Under Non-Fasting Conditions
- Comparison of 7-day and 14-day Bismuth Based Quadruple Therapy for Secondary Helicobacter Pylori Eradication
- Clarithromycin 500 mg Extended Release Tablets Under Fasting Conditions
- Clarithromycin 500 mg Extended Release Tablets Under Non-Fasting Conditions.
- Clarithromycin 500 mg Tablets Under Non-Fasting Conditions
- Clarithromycin 500 mg Tablets Under Fasting Conditions
- Levofloxacin Versus Clarithromycin Triple Therapy in First-Line Treatment for Helicobacter Pylori Eradication
- Bioequivaelnce Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fed Conditions
- Bioequivalence Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fasting Conditions
- Bioequivalence Study of Clarithromycin 500 mg Tablets Under Non-Fasting Conditions
- Bioequivalence Study of Clarithromycin 500mg Tablets Under Fasting Conditions.
- Bioequivalence Study of Clarithromycin 250mg Tablets Under Fasting Conditions
- Clarithromycin, Amoxicillin, and Metronidazole Based Regimens to Treat Helicobacter Pylori Infections in Colombia
- A Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin in Subjects With Community-acquired Pneumonia
- Study of the Ability of Clarithromycin to Induce Oxidative Stress
- Efficacy and Safety of Quadruple Therapy in Eradication of H. Pylori: A Comparison to Triple Therapy
- Comparison of Sequential or Concomitant Therapy for Helicobacter Pylori Infection
- Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fasting State
- Comparative Bioavailability Study of Clarithromycin 250 mg Tablets
- Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fed State
- Comparative Study of 5 Days of M02-472 Clarithromycin Extended-Release Tablets to 7 Days of Clarithromycin Immediate-Release Tablets for the Treatment of Exacerbation of Chronic Bronchitis
- Comparative Study of the Safety and Efficacy of Clarithromycin Extended-Release Tablets Versus Amoxicillin-Clavulanate for the Treatment of Acute Bacterial Sinusitis
- A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Clarithromycin Extended Release for the Treatment of Pneumonia in Adult Patients
- Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia
- Bioequivalency Study of Clarithromycin Tablets Under Fed Conditions
- Bioequivalency Study of Clarithromycin Tablets Under Fasting Conditions
- Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobacteria (NTM)
- Use of Clarithromycin and Rifabutin for the Treatment of M. Avium Complex (MAC) Lung Disease
- Phase II Study of Thalidomide, Clarithromycin, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma
- Quadruple Therapy for Triple Therapy Resistant Helicobacter Pylori Infection
- Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-like Receptors
- Treatment of Crohn's Disease With an Antibiotic Regimen Directed Against Mycobacterium Avium Paratuberculosis
- Safety of Rabeprazole in Patients Under Multiple Treatments
- Biaxin Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent Lymphoma
- Esomeprazole, Moxifloxacin and Amoxicilin for Rescue Therapy of Helicobacter Pylori Infection
- Esomeprazole Treatment for Patients With Lymphocytic Gastritis
- Lenalidomide, Dexamethasone, and Clarithromycin in Treating Patients Who Have Undergone Stem Cell Transplant for Multiple Myeloma
- Sequential Therapy Versus Triple Therapy for Helicobacter Pylori Eradication: a Placebo-controlled Trial
- Simvastatin as Inhibitor of Cell Adhesion Mediated Drug Resistance in Patients With Refractory Multiple Myeloma.
- Use of Clarithromycin in Mustard-Induced Bronchiolitis
- Clarithromycin v Ciprofloxacin Added to Rifampicin + Ethambutol, for Opportunist Mycobacterial Pulmonary Disease
- Antibiotics for the Treatment of Ulcerative Colitis
- Selection of Antibiotic Resistance by Azithromycin and Clarithromycin in the Oral Flora
- Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia
- Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia (CAP)
- Prospective Study of First-line Antibiotic Therapy for Early-stage Gastric MALT Lymphoma for Treatment Outcome
- BURULICO Drug Trial Study Protocol: RCT SR8/SR4+CR4, GHANA
- Asthma Clinical Research Network (ACRN) Trial - Macrolides in Asthma (MIA)
- Intravenous Clarithromycin in Septic Syndrome
- Is Helicobacter Pylori Infection a Cause or Treatment Failure of Iron Deficiency Anemia in Children in Bangladesh?
- The Influence of FP-10 on the Eradication Rates of H. Pylori by a Triple Therapy
- Clarithromycin in Active Crohn's Disease
- Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults.
- Nexium Study To Suppress Nausea During Chemotherapy
- Macrolide Antibiotic Therapy for Patients With Cystic Fibrosis
- Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection
- Thalidomide, Dexamethasone, and Clarithromycin in Treating Patients With Multiple Myeloma Previously Treated With Transplant
- Macrolides to Prevent Exacerbations of Asthma and Chronic Obstructive Pulmonary Disease
- Community-based Helicobacter Pylori Eradication
- Helicobacter - Lymphoma - Radiation Part I: Eradication, Part II: Radiation
- Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple Myeloma
- Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori
- Helicobacter Pylori Eradication With a New Sequential Treatment
- The CLARICOR Trial: Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease
- A Study to Compare the Efficacy and Safety of Levofloxacin in the Treatment of Children With Community-acquired Pneumonia in the Hospital or Outpatient Setting
- A Randomized, Double-Blinded, Placebo-Controlled, Phase II Inhaled Interferon Gamma-1b and Antimycobacterials to Treat Pulmonary Mycobacterium Avium Complex Infections
- Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma
- Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex Pulmonary Disease
- Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach
- Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma
- Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach
- The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients
- The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDS
- An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4.
- Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia.
- A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients
- A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo
- A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS
- Study of Four Different Treatment Approaches for Patients Who Have Mycobacterium Avium Complex Disease (MAC) Plus AIDS
- Evaluation of Treatment for Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients
- The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients
- The Safety and Effectiveness of Rifabutin, Combined With Clarithromycin or Azithromycin, in HIV-Infected Patients
- The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosine in the Treatment of Mycobacterium Avium Complex (MAC) Infections in Children With AIDS
- Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites
- Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis
- A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M. Avium Complex (MAC) Infections in Patients With AIDS
Clinical trials list
click for details